Erlotinib Viatris

Erlotinib Viatris is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer therapy.

Erlotinib Viatris is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a broader category of cancer treatments known as tyrosine kinase inhibitors.

Common effects of Erlotinib Viatris may include skin rash, diarrhea, and fatigue. Some users also report appetite loss and nausea. These effects can vary in intensity and duration, depending on individual factors. It's important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Erlotinib Viatris should be handled with care, as it is intended for oral use only. It is essential to follow the prescribed dosage and administration guidelines provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always keep it out of reach of children and pets.

Erlotinib Viatris may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.